Application of ultrasound in pulseless electrical activity (PEA) cardiac arrest
Authors
Abstract:
This article doesn't have abstract
similar resources
Tissue plasminogen activator in cardiac arrest with pulseless electrical activity.
BACKGROUND Coronary thrombosis and pulmonary thromboembolism are common causes of cardiac arrest. We assessed whether the administration of tissue plasminogen activator (t-PA) during cardiopulmonary resuscitation would benefit patients with cardiac arrest and pulseless electrical activity of unknown or presumed cardiovascular cause. METHODS Patients who were older than 16 years of age and who...
full textEstablishing An Asphyxial Pulseless Electrical Activity Arrest Model In Rabbits
Objective:Pulseless Electrical Activity (PEA) is an increasingly frequent cardiac rhythm in the arrested patient. We determined to establish an intact animal model of asphyxial PEA of variable duration that may be utilized for evaluation of agents of potential benefit in this scenario. Method:Instrumented adult New Zealand White rabbits underwent induction of hypoxic PEA via tracheal cross-clam...
full textCase 4 - 84-Year old female with precordial pain and cardiac arrest with pulseless electrical activity
Mailing Address: Vera Demarchi Aiello • bloco I, Cerqueira César. Postal Code 05403-000, São Paulo, SP Brazil E-mail: [email protected], [email protected]
full textAtropine, halothane, and pulseless electrical activity.
C ardiovascular depression from halothane overdose is a well-described cause of cardiac arrest in children undergoing anesthesia. In Salem et al’s (1) report of cardiac arrests in infants and children, seven of 73 were related to overdose of halothane. In Keenan and Boyan’s (2) landmark article on cardiac arrest due to anesthesia, five of six pediatric arrests were due to halothane excess, with...
full textMy Resources
Journal title
volume 30 issue 1
pages 509- 510
publication date 2016-01
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023